172 related articles for article (PubMed ID: 35093293)
1. Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.
Stokes WA; Xiong N; Liu Y; Higgins KA; Tian S; Bradley JD; Moghanaki D; Rusthoven CG
Clin Lung Cancer; 2022 May; 23(3):e231-e237. PubMed ID: 35093293
[TBL] [Abstract][Full Text] [Related]
2. Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
Lorenz J; Moghanaki D; Keshava H; Harpole DH; Bradley JD; Higgins KA; Rusthoven CG; Stokes WA
Lung Cancer; 2023 Jan; 175():57-59. PubMed ID: 36455397
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
[TBL] [Abstract][Full Text] [Related]
4. Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S; Taylor J; Sancheti M; Fernandez F; Moghanaki D
Chest; 2022 Mar; 161(3):833-844. PubMed ID: 34785235
[TBL] [Abstract][Full Text] [Related]
5. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
6. Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin.
Müller JA; Vordermark D; Medenwald D
Strahlenther Onkol; 2023 Jul; 199(7):658-667. PubMed ID: 36912978
[TBL] [Abstract][Full Text] [Related]
7. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
Stokes WA; Bronsert MR; Meguid RA; Blum MG; Jones BL; Koshy M; Sher DJ; Louie AV; Palma DA; Senan S; Gaspar LE; Kavanagh BD; Rusthoven CG
J Clin Oncol; 2018 Mar; 36(7):642-651. PubMed ID: 29346041
[TBL] [Abstract][Full Text] [Related]
8. Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer.
Khorfan R; Kruser TJ; Coughlin JM; Bharat A; Bilimoria KY; Odell DD
Ann Thorac Surg; 2020 Jul; 110(1):228-234. PubMed ID: 32147416
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
11. Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
Udelsman BV; Canavan ME; Zhan PL; Ely S; Park HS; Boffa DJ; Mase VJ
J Thorac Cardiovasc Surg; 2024 Mar; 167(3):822-833.e7. PubMed ID: 37500052
[TBL] [Abstract][Full Text] [Related]
12. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?
Onishi H; Shirato H; Nagata Y; Hiraoka M; Fujino M; Gomi K; Karasawa K; Hayakawa K; Niibe Y; Takai Y; Kimura T; Takeda A; Ouchi A; Hareyama M; Kokubo M; Kozuka T; Arimoto T; Hara R; Itami J; Araki T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1352-8. PubMed ID: 20638194
[TBL] [Abstract][Full Text] [Related]
16. Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non-Small Cell Lung Cancer?
Cao L; Linden PA; Biswas T; Worrell SG; Sinopoli JN; Miller ME; Shenk R; Montero AJ; Towe CW
J Surg Res; 2023 Mar; 283():532-539. PubMed ID: 36436290
[TBL] [Abstract][Full Text] [Related]
17. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer.
Amin SA; Alam M; Baine MJ; Meza JL; Bennion NR; Zhang C; Rahman I; Lin C
Radiother Oncol; 2021 Feb; 155():254-260. PubMed ID: 33317997
[TBL] [Abstract][Full Text] [Related]
18. Retrospective comparison between definitive stereotactic body radiotherapy and radical surgery for 538 patients with early-stage non-small cell lung cancer in a single institution.
Miki Y; Yamashita H; Nakajima J; Karasaki T; Kitano K; Katano A; Takenaka R; Ogita M; Sawayanagi S; Minamitani M; Jinnouchi H; Noyama T; Takeuchi K; Ishida A; Abe O
J Cancer Res Ther; 2023; 19(5):1350-1355. PubMed ID: 37787307
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
Mayne NR; Lin BK; Darling AJ; Raman V; Patel DC; Liou DZ; D'Amico TA; Yang CJ
Ann Surg; 2020 Dec; 272(6):925-929. PubMed ID: 33074904
[TBL] [Abstract][Full Text] [Related]
20. Role of stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients borderline for surgery due to impaired pulmonary function.
Tomita N; Okuda K; Kita N; Niwa M; Hashimoto S; Murai T; Ishikura S; Nakanishi R; Shibamoto Y
Asia Pac J Clin Oncol; 2022 Dec; 18(6):634-641. PubMed ID: 35098662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]